A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells

Journal of Leukocyte Biology

Volumn 95, Issue 5, 2014, Pages 733-742

  Xia, Siyuan ^a   Wei, Jun ^a   Wang, Jingya ^a   Sun, Huayan ^a   Zheng, Wenting ^a   Li, Yangguang ^a   Sun, Yanbo ^a   Zhao, Huiyuan ^a   Zhang, Song ^a   Wen, Ti ^a   Zhou, Xinglong ^a   Gao, Jian Xin ^b   Wang, Puyue ^a   Wu, Zhenzhou ^a   Zhao, Liqing ^a   Yin, Zhinan ^a  

^a NANKAI UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chemotaxis; Cytokine; Immunology; Lymphocytes

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 27; MACROPHAGE DERIVED CHEMOKINE; CCL22 PROTEIN, MOUSE; IFNG PROTEIN, MOUSE; IL27 PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; FIBROSARCOMA; IN VITRO STUDY; INTRACELLULAR SPACE; LYMPHOCYTIC INFILTRATION; LYMPHOMA CELL; MALE; MELANOMA B16; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; ANIMAL; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOMA; MELANOMA; PATHOLOGY;

ANIMALS; CELL MOVEMENT; CHEMOKINE CCL22; DENDRITIC CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; INTERFERON-GAMMA; INTERLEUKINS; LYMPHOMA; MELANOMA; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; T-LYMPHOCYTES, REGULATORY;

EID: 84899804081     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0713371     Document Type: Article

References (44)

1. Rabinovich, G. A., Gabrilovich, D., Sotomayor, E. M. (2007) Immunosuppressive strategies that are mediated by tumor cells. Ann. Rev. Immunol. 25, 267-296.
2. Dunn, G. P., Old, L. J., Schreiber, R. D. (2004) The three Es of cancer immunoediting. Ann. Rev. Immunol. 22, 329-360.
3. Itoh, M., Takahashi, T., Sakaguchi, N., Kuniyasu, Y., Shimizu, J., Otsuka, F., Sakaguchi, S. (1999) Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162, 5317-5326.
4. Sakaguchi, S., Yamaguchi, T., Nomura, T., Ono, M. (2008) Regulatory T cells and immune tolerance. Cell 133, 775-787.
5. Curiel, T. J. (2008) Regulatory T cells and treatment of cancer. Curr. Opin. Immunol. 20, 241-246.
6. Byrne, W. L., Mills, K. H., Lederer, J. A., O'Sullivan, G. C. (2011) Targeting regulatory T cells in cancer. Cancer Res. 71, 6915-6920.
7. Beyer, M., Schultze, J. L. (2006) Regulatory T cells in cancer Blood 108, 804-811.
8. Rech, A. J., Vonderheide, R. H. (2009) Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells. Ann. N. Y. Acad. Sci. 1174, 99-106.
9. Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., Zhu, Y., Wei, S., Kryczek, I., Daniel, B., Gordon, A., Myers, L., Lackner, A., Disis, M. L., Knutson, K. L., Chen, L., Zou, W. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10, 942-949.
10. Pflanz, S., Hibbert, L., Mattson, J., Rosales, R., Vaisberg, E., Bazan, J. F., Phillips, J. H., McClanahan, T. K., de Waal Malefyt, R., Kastelein, R. A. (2004) WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172, 2225-2231.
11. Wirtz, S., Becker, C., Fantini, M. C., Nieuwenhuis, E. E., Tubbe, I., Galle, P. R., Schild, H. J., Birkenbach, M., Blumberg, R. S., Neurath, M. F. (2005) EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-κ B activation. J. Immunol. 174, 2814-2824.
12. Wei, J., Xia, S., Sun, H., Zhang, S., Wang, J., Zhao, H., Wu, X., Chen, X., Hao, J., Zhou, X., Zhu, Z., Gao, X., Gao, J. X., Wang, P., Wu, Z., Zhao, L., Yin, Z. (2013) Critical role of dendritic cell-derived IL-27 in antitumor immunity through regulating the recruitment and activation of NK and NKT cells. J. Immunol. 191, 500-508.
13. Yoshida, H., Hamano, S., Senaldi, G., Covey, T., Faggioni, R., Mu, S., Xia, M., Wakeham, A. C., Nishina, H., Potter, J., Saris, C. J., Mak, T. W. (2001) WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15, 569-578.
14. Stumhofer, J. S., Silver, J. S., Laurence, A., Porrett, P. M., Harris, T. H., Turka, L. A., Ernst, M., Saris, C. J., O'Shea, J. J., Hunter, C. A. (2007) Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8, 1363-1371.
15. Awasthi, A., Carrier, Y., Peron, J. P., Bettelli, E., Kamanaka, M., Flavell, R. A., Kuchroo, V. K., Oukka, M., Weiner, H. L. (2007) A dominant function for interleukin 27 in generating interleukin 10-producing antiinflammatory T cells. Nat. Immunol. 8, 1380-1389.
16. Batten, M., Li, J., Yi, S., Kljavin, N. M., Danilenko, D. M., Lucas, S., Lee, J., de Sauvage, F. J., Ghilardi, N. (2006) Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7, 929-936.
17. Stumhofer, J. S., Laurence, A., Wilson, E. H., Huang, E., Tato, C. M., Johnson, L. M., Villarino, A. V., Huang, Q., Yoshimura, A., Sehy, D., Saris, C. J., O'Shea, J. J., Hennighausen, L., Ernst, M., Hunter, C. A. (2006) Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7, 937-945.
18. Lucas, S., Ghilardi, N., Li, J., de Sauvage, F. J. (2003) IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and-independent mechanisms. Proc. Natl. Acad. Sci. USA 100, 15047-15052.
19. Hunter, C. A., Kastelein, R. (2012) Interleukin-27: balancing protective and pathological immunity. Immunity 37, 960-969.
20. Ouaked, N., Mantel, P. Y., Bassin, C., Burgler, S., Siegmund, K., Akdis, C. A., Schmidt-Weber, C. B. (2009) Regulation of the Foxp3 gene by the Th1 cytokines: the role of IL-27-induced STAT1. J. Immunol. 182, 1041-1049.
21. Cox, J. H., Kljavin, N. M., Ramamoorthi, N., Diehl, L., Batten, M., Ghilardi, N. (2011) IL-27 promotes T cell-dependent colitis through multiple mechanisms. J. Exp. Med. 208, 115-123.
22. Wojno, E. D., Hosken, N., Stumhofer, J. S., O'Hara, A. C., Mauldin, E., Fang, Q., Turka, L. A., Levin, S. D., Hunter, C. A. (2011) A role for IL-27 in limiting T regulatory cell populations. J. Immunol. 187, 266-273.
23. Zhang, S., Liang, R., Luo, W., Liu, C., Wu, X., Gao, Y., Hao, J., Cao, G., Chen, X., Wei, J., Xia, S., Li, Z., Wen, T., Wu, Y., Zhou, X., Wang, P., Zhao, L., Wu, Z., Xiong, S., Gao, X., Chen, Y., Ge, Q., Tian, Z., Yin, Z. (2013) High susceptibility to liver injury in IL-27 p28 conditional knockout mice involves intrinsic interferon-γ dysregulation of CD4+ T cells. Hepatology 57, 1620-1631.
24. Hall, A. O., Beiting, D. P., Tato, C., John, B., Oldenhove, G., Lombana, C. G., Pritchard, G. H., Silver, J. S., Bouladoux, N., Stumhofer, J. S., Harris, T. H., Grainger, J., Wojno, E. D., Wagage, S., Roos, D. S., Scott, P., Turka, L. A., Cherry, S., Reiner, S. L., Cua, D., Belkaid, Y., Elloso, M. M., Hunter, C. A. (2012) The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infectioninduced pathology. Immunity 37, 511-523.
25. Steer, H. J., Lake, R. A., Nowak, A. K., Robinson, B. W. (2010) Harnessing the immune response to treat cancer. Oncogene 29, 6301-6313.
26. Gottfried, E., Kreutz, M., Mackensen, A. (2008) Tumor-induced modulation of dendritic cell function. Cytokine Growth Factor Rev. 19, 65-77.
27. Stumhofer, J. S., Tait, E. D., Quinn, W. J., 3rd, Hosken, N., Spudy, B., Goenka, R., Fielding, C. A., O'Hara, A. C., Chen, Y., Jones, M. L., Saris, C. J., Rose-John, S., Cua, D. J., Jones, S. A., Elloso, M. M., Grotzinger, J., Cancro, M. P., Levin, S. D., Hunter, C. A. (2010) A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat. Immunol. 11, 1119-1126.
28. Crabe, S., Guay-Giroux, A., Tormo, A. J., Duluc, D., Lissilaa, R., Guilhot, F., Mavoungou-Bigouagou, U., Lefouili, F., Cognet, I., Ferlin, W., Elson, G., Jeannin, P., Gauchat, J. F. (2009) The IL-27 p28 subunit binds cytokine-like factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling. J. Immunol. 183, 7692-7702.
29. Kohm, A. P., McMahon, J. S., Podojil, J. R., Begolka, W. S., DeGutes, M., Kasprowicz, D. J., Ziegler, S. F., Miller, S. D. (2006) Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J. Immunol. 176, 3301-3305.
30. Stranges, P. B., Watson, J., Cooper, C. J., Choisy-Rossi, C. M., Stonebraker, A. C., Beighton, R. A., Hartig, H., Sundberg, J. P., Servick, S., Kaufmann, G., Fink, P. J., Chervonsky, A. V. (2007) Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity 26, 629-641.
31. Wojno, E. D., Hunter, C. A. (2012) New directions in the basic and translational biology of interleukin-27. Trends Immunol. 33, 91-97.
32. Nishikawa, H., Sakaguchi, S. (2010) Regulatory T cells in tumor immunity. Int. J. Cancer 127, 759-767.
33. Smyth, M. J., Teng, M. W., Swann, J., Kyparissoudis, K., Godfrey, D. I., Hayakawa, Y. (2006) CD4+CD25+ T regulatory cells suppress NK cellmediated immunotherapy of cancer. J. Immunol. 176, 1582-1587.
34. Ghiringhelli, F., Menard, C., Martin, F., Zitvogel, L. (2006) The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression. Immunol. Rev. 214, 229-238.
35. Izhak, L., Ambrosino, E., Kato, S., Parish, S. T., O'Konek, J. J., Weber, H., Xia, Z., Venzon, D., Berzofsky, J. A., Terabe, M. (2013) Delicate balance among three types of T cells in concurrent regulation of tumor immunity. Cancer Res. 73, 1514-1523.
36. Menetrier-Caux, C., Gobert, M., Caux, C. (2009) Differences in tumor regulatory T-cell localization and activation status impact patient outcome. Cancer Res. 69, 7895-7898.
37. Gobert, M., Treilleux, I., Bendriss-Vermare, N., Bachelot, T., Goddard-Leon, S., Arfi, V., Biota, C., Doffin, A. C., Durand, I., Olive, D., Perez, S., Pasqual, N., Faure, C., Ray-Coquard, I., Puisieux, A., Caux, C., Blay, J. Y., Menetrier-Caux, C. (2009) Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 69, 2000-2009.
38. Mailloux, A. W., Clark, A. M., Young, M. R. (2010) NK depletion results in increased CCL22 secretion and Treg levels in Lewis lung carcinoma via the accumulation of CCL22-secreting CD11b+CD11c+ cells. Int. J. Cancer 127, 2598-2611.
39. Tan, M. C., Goedegebuure, P. S., Belt, B. A., Flaherty, B., Sankpal, N., Gillanders, W. E., Eberlein, T. J., Hsieh, C. S., Linehan, D. C. (2009) Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J. Immunol. 182, 1746-1755.
40. Jordan, J. T., Sun, W., Hussain, S. F., DeAngulo, G., Prabhu, S. S., Heimberger, A. B. (2008) Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy. Cancer Immunol. Immunother. 57, 123-131.
41. Molle, C., Nguyen, M., Flamand, V., Renneson, J., Trottein, F., De Wit, D., Willems, F., Goldman, M., Goriely, S. (2007) IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3. J. Immunol. 178, 7607-7615.
42. Gorina, R., Font-Nieves, M., Marquez-Kisinousky, L., Santalucia, T., Planas, A. M. (2011) Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways. Glia 59, 242-255.
43. Krumbiegel, D., Anthogalidis-Voss, C., Markus, H., Zepp, F., Meyer, C. U. (2008) Enhanced expression of IL-27 mRNA in human newborns. Pediatr. Allergy Immunol. 19, 513-516.
44. Mascanfroni, I. D., Yeste, A., Vieira, S. M., Burns, E. J., Patel, B., Sloma, I., Wu, Y., Mayo, L., Ben-Hamo, R., Efroni, S., Kuchroo, V. K., Robson, S. C., Quintana, F. J. (2013) IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nat. Immunol. 14, 1054-1063.